MS Flashcards

1
Q

Diagnostic Criteria + 3 Diagnostic Tools

A

Criteria

- At least 2 sep areas of CNS involvement; occur > 1 mo apart or progress over 1 yr
- Must have abnormal near exam
- Must r/o other explanations for neuro findings

Tools

  • CT not very useful (MRI much better) - look for white matter lesions (> 5 mm)
  • CSF - if inc IgG + might have elevated leukocytes
  • Evoked potential tests (picks up deficit but not cause)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 3 conditions are highly suspicious of MS?

A
  • Optic neuritis - unilateral vision loss & pain w/ eye movements (INFLAMMATION)
  • Internuclear opthalmoplegia (INO) - de-myelination of MLF (b/n CN IV & III nuc)
  • *trouble w/ medial rectus except for convergence
  • Partial myelitis - focal de-myelination of SC; associated w/ antibodies against aquaporin 4 in SC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathogenesis + Histology (acute and chronic)

A
  • Focal inflammation/de-myelination; immune response against CNS myelin
  • Histology
    • Where are the lesions? most commonly peri-ventricular lesions or follow post-capillary venues
    • Gliosis; oligodendrocyte loss; can have loss of axons themselves
    • Acute - contrast enhancing lesions
    • Chronic - global or multi-focal atrophy + black holes (axons, myelin and tissue matrix gone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epidemiology of MS

A
  • Women (75%) > men
  • Caucasian most common
  • Conc in US, UK, Canada, Australia, NZ
  • Mean age of onset = 28
  • Factors
    • 200+ genes (30% heritability in identical twins)
    • Also environments (tobacco, EBV, lack of vitamin D)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

5 Tx that Halt Progression

A
  • Interferon-beta - injections; dec T cell proliferation and dec MMPs
  • Copaxone (glatiramer acetate) - binds to MHC to compete w/ antigens; also injection
  • Natalizumab - antibody against VLA-4 which normally binds VCAM on endothelial cells; given as IV; RISK OF PML if have JC virus
  • Alemtuzumab - antibody against CD52 marker on all lymphocytes—> kills them; high risk of VIRAL infections
  • Ocrelizumab - only monoclonal antibody approved for primary progressive MS (antibody against CD20 on B cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you treat MS exacerbation?

A

Corticosteroids or ACTH injections (expensive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs for MS Symptom Management

A
  • Baclofen, stretching, cannabis for spasticity
  • Modanifil, amantadine for fatigue
  • Anticonvulsants of SNRIs for neuropathic pain
  • Bladder - use botulinum or anti-cholingerics/anti-muscarinics if hyperactive/spastics; use alpha agonists or self-cath if problem w/ emptying
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What makes MS better or worse?

A
  • What makes it worse?
    • Heat inc symptoms (Uhtoff’s phenomenon)
    • Infection triggers symptoms/exacerbations
  • What makes it better?
    • Pregnancy (dec exacerbation rate) - prolactin & estriol
    • May have inc risk of postpartum exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Symptoms

A
  • Exacerbations happen over hours to days and can last 4-12 wks in relapsing-remitting stage
  • Sensory = Loss or dec sensation; burning, tingling, tightness (MS hug), Loss of vibration/proprioception&raquo_space; pain/temp b/c dorsal columns more dependent on myelin, Vision problems (blurry or dbl vision or photopsias - flashes of light)
  • Motor = Weakness of 1 limb, both legs, half body; Spasticity; Hyperreflexive; pos Babinski; Gait ataxia, tremor, dysmetria
  • Brainstem = vertigo, slurred speech, trouble swallowing, nystagmus, facial pain/weakness/numbness
  • Cognitive = Depression, anxiety; Fatigue; Lhermitte’s Phenomenon - electric shock w/ neck flexion
  • Other = Bladder retention, urgency, incontinence; constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly